Published in BMC Pulm Med on December 03, 2016
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med (2007) 2.85
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest (1998) 2.57
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52
Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry (2011) 1.92
Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord (2007) 1.89
Smoking, nicotine dependence and psychiatric comorbidity--a population-based study including smoking cessation after three years. Drug Alcohol Depend (2004) 1.86
Relationship between depression and exacerbations in COPD. Eur Respir J (2008) 1.81
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc (2015) 1.72
Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc (2011) 1.65
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J (2009) 1.62
Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine (2012) 1.52
Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage (2009) 1.31
Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest (2007) 1.16
Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med (2011) 1.01
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clin Chest Med (2014) 0.89
Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort. PLoS One (2014) 0.86
Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary disease. Heart Lung (2013) 0.84
Depressive symptoms, inflammatory markers and body composition in elderly with and without chronic obstructive pulmonary disease (COPD). Arch Gerontol Geriatr (2011) 0.83
Dyspnea and pain frequently co-occur among Medicare managed care recipients. Ann Am Thorac Soc (2014) 0.82
Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med (2014) 0.82
Is high-sensitive C-reactive protein a biomarker for functional somatic symptoms? A population-based study. Brain Behav Immun (2009) 0.78
Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease. J Clin Nurs (2014) 0.77
COPD disease severity and innate immune response to pathogen-associated molecular patterns. Int J Chron Obstruct Pulmon Dis (2016) 0.77
The Consequences of Contact with the Criminal Justice System for Health in the Transition to Adulthood. Longit Life Course Stud (2017) 0.75